home / stock / prfx / prfx quote
Last: | $1.82 |
---|---|
Change Percent: | 0.0% |
Open: | $1.78 |
Close: | $1.82 |
High: | $1.89 |
Low: | $1.78 |
Volume: | 3,785 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.82 | $1.78 | $1.82 | $1.89 | $1.78 | 3,785 | 03-29-2024 |
$1.82 | $1.78 | $1.82 | $1.89 | $1.78 | 2,665 | 03-28-2024 |
$1.78 | $1.8 | $1.78 | $1.9103 | $1.78 | 10,279 | 03-27-2024 |
$1.8 | $1.8011 | $1.8 | $1.8737 | $1.8 | 9,101 | 03-26-2024 |
$1.8 | $1.85 | $1.8 | $2.005 | $1.8 | 15,317 | 03-25-2024 |
$1.78 | $2.06 | $1.78 | $2.2466 | $1.78 | 67,868 | 03-22-2024 |
$1.97 | $1.92 | $1.97 | $2.03 | $1.92 | 4,362 | 03-21-2024 |
$1.92 | $1.9217 | $1.92 | $1.9217 | $1.9 | 3,064 | 03-20-2024 |
$1.8873 | $1.88 | $1.8873 | $1.89 | $1.8535 | 8,046 | 03-19-2024 |
$1.84 | $1.865 | $1.84 | $1.896 | $1.84 | 4,634 | 03-18-2024 |
$1.84 | $1.8901 | $1.84 | $1.97 | $1.84 | 11,659 | 03-15-2024 |
$1.89 | $1.99 | $1.89 | $1.9981 | $1.89 | 3,322 | 03-14-2024 |
$1.95 | $1.96 | $1.95 | $2.04 | $1.94 | 5,027 | 03-13-2024 |
$2 | $1.96 | $2 | $2 | $1.92 | 12,145 | 03-12-2024 |
$2.078 | $1.96 | $2.078 | $2.09 | $1.95 | 7,981 | 03-11-2024 |
$1.98 | $2.07 | $1.98 | $2.13 | $1.9233 | 52,789 | 03-08-2024 |
$2.09 | $2.1216 | $2.09 | $2.1216 | $2.04 | 1,742 | 03-07-2024 |
$2.04 | $2.14 | $2.04 | $2.14 | $2.02 | 7,677 | 03-06-2024 |
$2.06 | $2.0993 | $2.06 | $2.2453 | $2.03 | 21,836 | 03-05-2024 |
$2.1 | $2.2 | $2.1 | $2.27 | $2 | 56,050 | 03-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
PainReform Ltd. Company Name:
PRFX Stock Symbol:
NASDAQ Market:
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce top-line data by mid- 2024 TEL AVIV, Israel, March 01, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd . (Nasdaq: PRFX) (" P...